Unlock stock picks and a broker-level newsfeed that powers Wall Street.
ASX - Delayed Quote AUD

Wellnex Life Limited (WNX.AX)

Compare
0.3400
-0.0200
(-5.56%)
At close: 3:37:35 PM GMT+11
Loading Chart for WNX.AX
  • Previous Close 0.3600
  • Open 0.3500
  • Bid 0.3450 x --
  • Ask 0.3500 x --
  • Day's Range 0.3300 - 0.3500
  • 52 Week Range 0.3200 - 1.6000
  • Volume 52,301
  • Avg. Volume 74,157
  • Market Cap (intraday) 22.823M
  • Beta (5Y Monthly) 1.06
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1600
  • Earnings Date Feb 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness solutions in Australia and internationally. The company offers medicinal cannabis under the Wellness Life brand; topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; sleep aid products under the Nighty Night brand; caffeine energy supplements under the Wakey Wakey brand; iron gummies under The Iron Company brand; teeth whitening products under the Mr Bright brand; over-the-counter medicines under the Pharmacy Own brand; and pain relief product under the Wagner Liquigesics brand. It also provides organic baby skincare, aromatherapy essential oils, and domestic cleaning products; and contract manufacturing services. In addition, the company licenses intellectual properties and trademarks of its products. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.

wellnexlife.com.au

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: WNX.AX

View More

Performance Overview: WNX.AX

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

WNX.AX
48.48%
S&P/ASX 200 [XJO] (^AXJO)
5.99%

1-Year Return

WNX.AX
72.80%
S&P/ASX 200 [XJO] (^AXJO)
1.32%

3-Year Return

WNX.AX
92.53%
S&P/ASX 200 [XJO] (^AXJO)
2.09%

5-Year Return

WNX.AX
98.21%
S&P/ASX 200 [XJO] (^AXJO)
51.37%

Compare To: WNX.AX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: WNX.AX

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    24.17M

  • Enterprise Value

    36.25M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.43

  • Price/Book (mrq)

    7.94

  • Enterprise Value/Revenue

    1.56

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -49.54%

  • Return on Assets (ttm)

    -8.01%

  • Return on Equity (ttm)

    -240.96%

  • Revenue (ttm)

    23.24M

  • Net Income Avi to Common (ttm)

    -11.51M

  • Diluted EPS (ttm)

    -0.1600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    280k

  • Total Debt/Equity (mrq)

    406.48%

  • Levered Free Cash Flow (ttm)

    10.91M

Research Analysis: WNX.AX

View More

Company Insights: WNX.AX

Research Reports: WNX.AX

View More

People Also Watch